51 related articles for article (PubMed ID: 19317653)
1. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A
Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653
[TBL] [Abstract][Full Text] [Related]
2. The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study.
Wang Q; Zheng Y; Wang P; Zhang J; Liu H; Li Q; Yin R; Bian C; Peng H; Peng Z
J Ovarian Res; 2021 Dec; 14(1):179. PubMed ID: 34930386
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
Johnson CC; Kessel B; Riley TL; Ragard LR; Williams CR; Xu JL; Buys SS;
Gynecol Oncol; 2008 Sep; 110(3):383-9. PubMed ID: 18586313
[TBL] [Abstract][Full Text] [Related]
4. CA 72-4 serum marker--a new tool in the management of carcinoma patients.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Cavaliere F; Casaldi V; Wappner G; Abbolito MR; Greiner JW
Cancer Invest; 1995; 13(2):227-38. PubMed ID: 7874576
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence.
Joypaul B; Browning M; Newman E; Byrne D; Cuschieri A
Am J Surg; 1995 Jun; 169(6):595-9. PubMed ID: 7771623
[TBL] [Abstract][Full Text] [Related]
6. Management of borderline ovarian tumors: A tertiary referral center experience in Egypt.
Gaballa K; Abdelkhalek M; Fathi A; Refky B; Belal K; Elaraby M; Zuhdy M
Front Surg; 2022; 9():962820. PubMed ID: 36117821
[TBL] [Abstract][Full Text] [Related]
7. Characterizing omental PET/CT findings for differentiating tuberculous peritonitis from peritoneal carcinomatosis.
Duan H; Xu D; Lu R; Wang S; Xie R; Wang S
Abdom Radiol (NY); 2021 Dec; 46(12):5574-5585. PubMed ID: 34549331
[TBL] [Abstract][Full Text] [Related]
8. NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.
Xin B; Ji KQ; Liu YS; Zhao XD
Reprod Sci; 2021 Mar; 28(3):745-756. PubMed ID: 33125687
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Tuberculosis: A Forsaken Yet Misleading Diagnosis.
Kattan J; Haddad FG; Menassa-Moussa L; Kesrouani C; Daccache S; Haddad FG; Atallah D
Case Rep Oncol Med; 2019; 2019():5357049. PubMed ID: 31781444
[TBL] [Abstract][Full Text] [Related]
10. Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis.
Shin KH; Kim HH; Kwon BS; Suh DS; Joo JK; Kim KH
Ann Lab Med; 2020 Jan; 40(1):40-47. PubMed ID: 31432638
[TBL] [Abstract][Full Text] [Related]
11. Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Xin B; Ji KQ; Liu YS; Zhao XD
J Ovarian Res; 2019 Aug; 12(1):75. PubMed ID: 31399054
[TBL] [Abstract][Full Text] [Related]
12. Ykl-40 and cancer antigen 72-4 as new and promising diagnostic and prognostic markers for endometrial cancer.
Karataş S; Şal V; Kahramanoğlu İ; Demirkıran F; Beşe T; Arvas M; Sofiyeva N; Güralp O; Uzun H
Turk J Obstet Gynecol; 2018 Dec; 15(4):235-242. PubMed ID: 30693139
[TBL] [Abstract][Full Text] [Related]
13. The Complementary Role of Imaging and Tumor Biomarkers in Gynecological Cancers: An Update of the Literature.
Anastasi E; Gigli S; Ballesio L; Angeloni A; Manganaro L
Asian Pac J Cancer Prev; 2018 Feb; 19(2):309-317. PubMed ID: 29479951
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Preoperative Serum Levels of CA 125 and Expression of p53 in Ovarian Neoplasms: A Prospective Clinicopathological Study in a Tertiary Care Hospital.
Tiwari RK; Saha K; Mukhopadhyay D; Datta C; Chatterjee U; Ghosh TK
J Obstet Gynaecol India; 2016 Apr; 66(2):107-14. PubMed ID: 27046964
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy.
Liu P; Zhu Y; Liu L
Oncotarget; 2015 Apr; 6(11):9592-9. PubMed ID: 25860937
[TBL] [Abstract][Full Text] [Related]
17. Fertility sparing treatment in borderline ovarian tumours.
Alvarez RM; Vazquez-Vicente D
Ecancermedicalscience; 2015; 9():507. PubMed ID: 25729420
[TBL] [Abstract][Full Text] [Related]
18. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?
Anastasi E; Manganaro L; Granato T; Benedetti Panici P; Frati L; Porpora MG
Dis Markers; 2013; 35(5):331-5. PubMed ID: 24191126
[TBL] [Abstract][Full Text] [Related]
19. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.
Anastasi E; Granato T; Falzarano R; Storelli P; Ticino A; Frati L; Panici PB; Porpora MG
J Ovarian Res; 2013 Jul; 6(1):44. PubMed ID: 23816286
[TBL] [Abstract][Full Text] [Related]
20. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Romeo M; Pons F; Barretina P; Radua J
World J Surg Oncol; 2013 Jan; 11():13. PubMed ID: 23343188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
